Harvard Apparatus Regenerative Technology Inc (HRGN)

Currency in USD
1.360
0.000(0.00%)
Closed·
HRGN Scorecard
Full Analysis
Analysts anticipate sales growth in the current year
HRGN is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1.3601.440
52 wk Range
0.9365.900
Key Statistics
Prev. Close
1.36
Open
1.44
Day's Range
1.36-1.44
52 wk Range
0.936-5.9
Volume
764
Average Volume (3m)
2.73K
1-Year Change
-45.6%
Book Value / Share
0.13
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
HRGN Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Stock price often moves in the opposite direction of the market
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Harvard Apparatus Regenerative Technology Inc Company Profile

Harvard Apparatus Regenerative Technology Inc., a clinical-stage biotechnology company, focuses on developing regenerative-medicine treatments for disorders of the gastro-intestinal system and other organs resulting from cancer, trauma, or birth defects. Its lead product candidate is Cellspan Esophageal Implant for the treatment of severe esophageal disease. The company’s pipeline includes organ-regeneration technology for the repair or replacement of diseased or damaged organs; and product candidates to treat conditions of the esophagus, including traumatic injury, caustic burns, tissue damage following chemoradiation therapy, birth defects, and reconstruction of the colon and uterus wound repair. It also sells consumer health products that focuses on personal healthcare, including dietary supplements. Harvard Apparatus Regenerative Technology Inc. was formerly known as Biostage, Inc. and changed its name to Harvard Apparatus Regenerative Technology Inc. in July 2023. The company was founded in 2009 and is headquartered in Holliston, Massachusetts.

Compare HRGN to Peers and Sector

Metrics to compare
HRGN
Peers
Sector
Relationship
P/E Ratio
−3.2x−3.7x−0.5x
PEG Ratio
−0.18−0.200.00
Price/Book
11.4x5.2x2.6x
Price / LTM Sales
55.9x9.3x3.2x
Upside (Analyst Target)
-169.6%45.7%
Fair Value Upside
Unlock20.7%8.6%Unlock

Earnings

Latest Release
May 30, 2025
EPS / Forecast
-0.10 / --
Revenue / Forecast
45.00K / --
EPS Revisions
Last 90 days

HRGN Income Statement

FAQ

What Stock Exchange Does Harvard Apparatus Regenerative Tech Trade On?

Harvard Apparatus Regenerative Tech is listed and trades on the OTC Markets stock exchange.

What Is the Stock Symbol for Harvard Apparatus Regenerative Tech?

The stock symbol for Harvard Apparatus Regenerative Tech is "HRGN."

What Is the Harvard Apparatus Regenerative Tech Market Cap?

As of today, Harvard Apparatus Regenerative Tech market cap is 23.35M.

What Is Harvard Apparatus Regenerative Tech's Earnings Per Share (TTM)?

The Harvard Apparatus Regenerative Tech EPS (TTM) is -0.48.

When Is the Next Harvard Apparatus Regenerative Tech Earnings Date?

Harvard Apparatus Regenerative Tech will release its next earnings report on 18 Aug 2025.

From a Technical Analysis Perspective, Is HRGN a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Harvard Apparatus Regenerative Tech Stock Split?

Harvard Apparatus Regenerative Tech has split 1 times.

How Many Employees Does Harvard Apparatus Regenerative Tech Have?

Harvard Apparatus Regenerative Tech has 8 employees.

What is the current trading status of Harvard Apparatus Regenerative Tech (HRGN)?

As of 03 Aug 2025, Harvard Apparatus Regenerative Tech (HRGN) is trading at a price of 1.36, with a previous close of 1.36. The stock has fluctuated within a day range of 1.36 to 1.44, while its 52-week range spans from 0.94 to 5.90.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.